Mikolaj Laszkiewicz

Avatar photo

An experienced journalist and editor passionate about new technologies, computers, and scientific discoveries. He strives to bring a unique perspective to every topic. A law graduate.

Biohub, the organization financially backed by Mark Zuckerberg and Priscilla Chan, has announced the launch of the $500 million “Virtual Biology Initiative.” The massive investment aims to build advanced artificial intelligence models capable of accurately simulating human cell behavior in a virtual environment, a move expected to radically accelerate drug discovery for the most severe diseases

American startup OpenEvidence has scrapped plans to enter the European Union and UK markets, citing fears over the fallout from the AI Act. However, developers of European AI systems explain why these stringent regulations – while deterring global players – are ultimately meant to build the world’s safest medical ecosystem.

Seven families of victims from the tragic shooting in Tumbler Ridge, Canada, have filed lawsuits in federal court in San Francisco against OpenAI and Sam Altman. The plaintiffs allege the tech giant’s leadership deliberately concealed the 18-year-old shooter’s violent plans from the police, ignoring direct reports from its own safety team.

Swedish Tesla owners are one step closer to utilizing Full Self-Driving (FSD). Following its January debut in the city of Nacka, Strängnäs is joining the supervised testing program. Although drivers won’t receive this feature overnight, the rollout of the pilot program is a crucial legal step in getting this technology approved for the Scandinavian market.

New regulations governing the conduct of clinical trials in the UK come into effect today. This marks the largest package of changes in this sector in over two decades. Thanks to simplified procedures for lower-risk trials and the introduction of fast-track assessment routes, the preparation time for medical tests has already been reduced to 122 days. Furthermore, the publication of trial results becomes a strict legal requirement for the first time.

Imagine a fleet of microscopic machines cruising through your body, vacuuming up dangerous bacteria, and then dropping them off at a designated location on demand. This is no longer a sci-fi movie scenario. Researchers have just unveiled ultra-fast, light-driven nanorobots that could revolutionize medicine and the way we deliver drugs.